LAUSR

About LAUSR
Donate
Contact Us

Follow us:

You are not signed in:

Sign Up!


   Articles with "genentech" as a keyword



PATIENT‐REPORTED EXPERIENCE AND PREFERENCES WITH TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AND FOLLICULAR LYMPHOMA (FL)

Sign Up to like & get
recommendations! Published in 2019 at "Hematological Oncology"

DOI: 10.1002/hon.225_2631

Abstract: There is no connection between an RTI employee's compensation and the projects on which they work. Information about projects with other clients is confidential. Comenencia-Ortíz, E: Employment Leadership Position: Roche, Genentech; Stock Ownership: Roche, Genentech;… read more here.

Keywords: time; treatment; lymphoma; genentech ... See more keywords

Genentech's Ocrevus heralds new chapter in MS treatment

Sign Up to like & get
recommendations! Published in 2017 at "Nature Biotechnology"

DOI: 10.1038/nbt0517-393

Abstract: 393 The widely anticipated FDA approval of Genentech’s CD20-targeting antibody Ocrevus (ocrelizumab) for treating both relapsing and primary progressive forms of multiple sclerosis (MS), on March 28, marks the beginning of a new era in… read more here.

Keywords: genentech; treatment; genentech ocrevus; drug ... See more keywords

FRI0262 CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS WITH POLYMYALGIA SYMPTOMS ONLY VS CRANIAL SYMPTOMS ONLY TREATED WITH TOCILIZUMAB OR PLACEBO IN THE GIACTA TRIAL

Sign Up to like & get
recommendations! Published in 2019 at "Annals of the Rheumatic Diseases"

DOI: 10.1136/annrheumdis-2019-eular.1379

Abstract: Background GiACTA, a randomized, double-blind, placebo (PBO)–controlled study, demonstrated the efficacy and safety of tocilizumab (TCZ) in patients with giant cell arteritis (GCA).1 Growing evidence has shown that TCZ is also effective for the treatment… read more here.

Keywords: prednisone; pmr symptoms; tcz; roche ... See more keywords

COVID-19 in patients with CLL: improved survival outcomes and update on management strategies

Sign Up to like & get
recommendations! Published in 2021 at "Blood"

DOI: 10.1182/blood.2021011841

Abstract: Conflict of interest: COI declared see note COI notes: LER has served as a consultant for AbbVie, AstraZeneca, Pharmacyclics, Vaniam group, and Verastem, holds minority ownership interest in Abbott Laboratories, and has received research funding… read more here.

Keywords: research; abbvie; genentech; janssen ... See more keywords